Who invested in MerLion Pharmaceuticals?
MerLion Pharmaceuticals's investors include Bio*One Capital, Aravis Ventures and Aurelia Private Equity.
Singapore · Series C startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 1 round since 2010, from 1 source
MerLion Pharmaceuticals's investors include Bio*One Capital, Aravis Ventures and Aurelia Private Equity.
MerLion Pharmaceuticals has raised $7.0M across 1 round since 2010.
MerLion Pharmaceuticals's most recent round was a Series C of $7.0M in Oct 2010.
Its most recent round, $7.0M in Oct 2010, is also its largest on record.
MerLion Pharmaceuticals's first round on record, in Oct 2010, was backed by Bio*One Capital, Aravis Ventures and Aurelia Private Equity.
MerLion Pharmaceuticals's latest named round is a Series C, in Oct 2010.
MerLion Pharmaceuticals is based in Singapore.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.